Enzymotec Ltd. (ENZY) in Focus: Stock Up 5.2%

Zacks


Enzymotec Ltd. (ENZY) was a big mover last session, as the company saw its shares rise a little over 5% on the day. This rally higher can be attributable to solid volume too with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $25.34 to $29.25 in the past one-month time frame, showed a pick-up yesterday at $27.31.

The company has seen 2 positive revisions in the past month, while its Zacks Consensus Estimate moved higher over the same period, suggesting that more solid trading could be ahead for Enzymote. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
    
Enzymote currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is negative.

Some other players in the healthcare industry include Alexion Pharmaceuticals, Inc. (ALXN), with a Zacks Rank #1 (Strong Buy) along with Actelion Ltd. (ALIOF) and Cambrex Corporation.(CBM) holding a Zacks Rank #2 (Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>





ENZYMOTEC LTD ORD (ENZY): Free Stock Analysis Report

ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report


Zacks Investment Research

View Comments (0)

Recommended for You